Table 2.
Headline | China’s vaccines better suit Africa, LatAm due to ‘lower costs, easier logistics’ |
Length | 638 words |
Key features | The report focuses on the positive representation of China’s vaccines and the negative representation of US vaccines. According to Global Times, China’s inactivated vaccines have lower costs and simple logistics than the complicated mRNA technology in Pfizer and Moderna vaccines. Due to their lower costs and simplicity, China’s vaccines are better suit poor African and Latin – American countries than the expensive and complex US vaccines |